Inhaled Administration
Inhaled Administration is a route of drug delivery that involves the introduction of a therapeutic agent into the respiratory system via inhalation, distinguishing it from other administration routes by targeting pulmonary tissues directly for local or systemic absorption.
1.2K
Publications
58.5K
Citations
6.1K
Authors
1.6K
Institutions
Publications per year
2017–2026
180
Variants
Inhalation AdministrationInhalation Route
Parents
1.2K
Large Porous Particles for Pulmonary Drug Delivery
David A. Edwards, Justin Hanes, Giovanni Caponetti et al. · Science · 1997 · 1.2K citations
D W Cockcroft, K.Y. Murdock · Journal of Allergy and Clinical Immunology · 1987 · 494 citations
Paul Meers, Mary E. Neville, Vladimir Malinin et al. · Journal of Antimicrobial Chemotherapy · 2008 · 337 citations · Full text
1–5 of 1.2K
6.1K
13
h-index
12
h-index
10
h-index
10
h-index
10
h-index
1–5 of 6.1K
1.6K

Imperial College London
London, United Kingdom
18 h-index
47 publications
1.9K citations

McMaster University
Hamilton, Canada
18 h-index
77 publications
6.2K citations

Research Triangle Park Foundation
Durham, United States
17 h-index
64 publications
2.2K citations
Massachusetts General Hospital
Boston, United States
17 h-index
105 publications
9.8K citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
16 h-index
113 publications
4.7K citations

Southampton General Hospital
Southampton, United Kingdom
16 h-index
67 publications
3.9K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
15 h-index
69 publications
3.4K citations
Royal Brompton Hospital
London, United Kingdom
14 h-index
41 publications
1.4K citations
1–8 of 1.6K
AJRCCM · 44 publications · 5.1K citations
36
h-index
Repository · 82 publications · 3.4K citations
33
h-index
48 publications · 2.3K citations
30
h-index
32 publications · 1.4K citations
24
h-index
27 publications · 1.9K citations
24
h-index
1–5